-
QBIO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
Q BioMed (QBIO)
Company Profile
Quarter (USD) | Feb 23 | Nov 22 | Aug 22 | May 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Nov 22 | Nov 21 | Nov 20 | Nov 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 49.97 k | 49.97 k | 49.97 k | 49.97 k | 49.97 k | 49.97 k |
Cash burn (monthly) | 98.01 k | 7.27 k | 148.34 k | 227.18 k | 46.06 k | (no burn) |
Cash used (since last report) | 2.31 mm | 170.97 k | 3.49 mm | 5.34 mm | 1.08 mm | n/a |
Cash remaining | -2.26 mm | -121.00 k | -3.44 mm | -5.29 mm | -1.03 mm | n/a |
Runway (months of cash) | -23.0 | -16.6 | -23.2 | -23.3 | -22.4 | n/a |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 10.21 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
YA II PN | 10.21 mm | $0.00 |